| Literature DB >> 31591914 |
Paul Zarogoulidis1, Konstantinos Sapalidis1, Varvara Fyntanidou2, Christoforos Kosmidis1, Aikaterini Amaniti2, Charilaos Koulouris1, Dimitrios Giannakidis1, Kosmas Tsakiridis3, Zoi Aidoni1, Konstantinos Romanidis4, Panagoula Oikonomou4, Haidong Huang5, Lutz Freitag6, Wolfgang Hohenforst-Schmidt7.
Abstract
Introduction: Non-small cell lung cancer is still diagnosed at a late stage although we have new diagnostic equipment such the radial endobronchial ultrasound, convex probe endobronchial ultrasound, and electromagnetic navigation. The diagnostic techniques have been upgraded with rapid on-site evaluation (ROSE) and currently from 2014 real-time elastography is being evaluated as a ROSE technique.Areas covered: A thorough search was performed on PubMed and Scopus with the following key words: elastography, strain ratio, convex probe EBUS, endoscopic ultrasound (EUS), elastography. In the current mini review, we will focus on published data regarding elastography with the convex probe endobronchial ultrasound in two different systems and comment on this future ROSE technique. Elastography, strain ratio, and factors such as(I) margin (indistinct or distinct); (II) shape (oval or round); (III) short-axis size less or more than 1 cm; (IV) presence or absence of central hilar structure (CHS); (V) echogenicity (homogeneous or heterogeneous); and (VI) presence or absence of coagulation necrosis sign are presented in our review based on published literature.Expert opinion: Current data indicate that we can have up to 93% sensitivity and specificity of real-time elastography and strain ratio for the evaluation of benignancy and malignancy; however, sample biopsy is still necessary. For now, we can only reduce the number of punctures.Entities:
Keywords: EBUS; Lung cancer; NSCLC; elastography; endobronchial ultrasound; strain ratio
Year: 2019 PMID: 31591914 DOI: 10.1080/17476348.2019.1677466
Source DB: PubMed Journal: Expert Rev Respir Med ISSN: 1747-6348 Impact factor: 3.772